基于夫妇的孕前血清维生素D状态对生育结局影响的目标试验模拟
该研究为叶酸和锌补充试验的二次分析,纳入美国四中心2013-2017年寻求不孕治疗的2370对夫妇,采用目标试验模拟框架评估孕前25-羟维生素D水平与活产、流产及精液质量的关联。结果显示女性维生素D充足与活产可能性升高相关,未观察到与流产或精液质量的关联,体质指数分层分析显示关联存在异质性。
要点
- 女性孕前25(OH)D充足者活产可能性较缺乏者高28%(95%CI 1.05-1.56)。
- 体质指数正常者中,夫妇双方维生素D充足均与活产相关(女性aRR 1.39,男性aRR 1.51)。
- 未观察到孕前维生素D状态与流产或精液质量的关联。
核心结论
- 孕前维生素D状态和生物利用度影响寻求不孕治疗夫妇的生育结局,可能与精液质量无关。
- 体质指数分层分析显示关联存在异质性。
研究设计与样本
- 叶酸和锌补充试验的二次分析,采用目标试验模拟框架。
- 夫妇在美国四个中心招募(2013-2017年),观察9个月或直至妊娠。
- 共纳入2370对寻求不孕治疗的夫妇。
主要发现
- 女性中19.5%缺乏25(OH)D,男性中29.9%缺乏。
- 女性25(OH)D充足者活产可能性较缺乏者高28%(95%CI 1.05-1.56)。
- 体质指数正常者中,女性充足vs缺乏aRR 1.39(95%CI 1.00-1.99),男性充足vs缺乏aRR 1.51(95%CI 1.01-2.25)。
- 肥胖女性伴侣中,充足vs缺乏aRR 1.33(95%CI 0.95-1.85)。
- 夫妇双方均不缺乏vs双方均缺乏aRR 1.26(95%CI 1.00-1.58)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate associations between preconception 25-hydroxyvitamin D (25(OH)D) levels and biomarkers in female and male partners on live birth (LB), pregnancy loss, and semen quality. DESIGN: Secondary analysis using the folic acid and zinc supplementation trial of couples seeking infertility treatment at four US centers (2013-2017). A target trial emulation framework was applied to estimate associations. Couples were observed for 9 months or through pregnancy. SUBJECTS: Couples seeking infertility treatment. INTERVENTION(S): Preconception concentrations of 25(OH)D (primary) and associated biomarkers: vitamin D binding protein, calcium, free vitamin D, bioavailable vitamin D. MAIN OUTCOME MEASURE(S): Live birth and pregnancy loss were ascertained via self-report and medical records. Semen quality was ascertained 6 months after enrollment. Log-binomial regression estimated risk ratios and 95% confidence intervals (CIs). Individual and joint models and effect measure modification by preconception body mass index were considered. RESULT(S): Among 2,370 couples, 19.5% of females and 29.9% of males were 25(OH)D deficient. Females with sufficient status had a 28%-higher likelihood of LB than deficient females (95% CI, 1.05-1.56). Female and male 25(OH)D status were associated with LB among those with normal body mass index (sufficient vs. deficient: female adjusted risk ratio [aRR], 1.39; 95% CI, 1.00-1.99; male aRR, 1.51; 95% CI, 1.01-2.25) and among obese female partners (sufficient vs. deficient: aRR, 1.33; 95% CI, 0.95-1.85). Couples whose both partners had higher 25(OH)D status had increased likelihood of LB (both not deficient vs. both deficient aRR, 1.26; 95% CI, 1.00-1.58). No associations were observed with pregnancy loss or semen quality. Similar results were found for all biomarkers except calcium. CONCLUSION(S): Preconception vitamin D status and bioavailability impact fertility among couples seeking infertility therapy, likely unrelated to semen quality. Body mass index stratified analyses demonstrated heterogeneous associations. CLINICAL TRIAL REGISTRATION NUMBER: NCT01857310.
引用
- DiTosto JD, Caniglia EC, Hinkle SN, et al. Target trial emulation of preconception serum vitamin D status on fertility outcomes: a couples-based approach. Fertil Steril. 2024. PMID: 39173703. doi:10.1016/j.fertnstert.2024.08.332
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。